Research Clinical Trials Obesity
A new device for weight loss — a swallowable gastric balloon that requires no invasive procedures — may soon be approved by the U.S. Food and Drug Administration (FDA) after a nationwide clinical trial that is being overseen by Shelby Sullivan, MD, professor of gastroenterology at the University of Colorado School of Medicine and director of the Metabolic and Bariatric Program.
Research Community Public Health Obesity
The diet a mother consumes while pregnant may increase the risk for non-alcoholic fatty liver disease (NAFLD) in the offspring, new research shows.
Following up on a 2018 study that identified an epigenetic modifier known as histone deacetylase 11 (HDAC11) as a potential therapeutic target for treating obesity and diabetes, researchers from the University of Colorado School of Medicine have published new research that finds HDAC11 regulates G protein-coupled receptors (GPCRs) called beta-adrenergic receptors (β-ARs).
Healio
April 18, 2024
Due to structural racism, Black and Latin populations have been exposed to more particulate air pollution, Stephanie Johannes, an allergy and immunology fellow at Children’s Hospital Colorado, said during her presentation.
The Denver Post
April 18, 2024
First lady Jill Biden plans to stop in Aurora this weekend to promote the White House Initiative on Women’s Health Research.
KMGH Channel 7
April 18, 2024
First Lady Jill Biden will visit Colorado this weekend to speak about a White House initiative seeking to change how the country approaches and funds research on women’s health.
Becker's Hospital Review
April 18, 2024
Physicians and researchers say more data is needed on pregnancy outcomes in patients taking GLP-1s as a growing number of women turn to the class of weight loss medications in hopes of reducing their risk of pregnancy complications or increasing their chance of conceiving, Bloomberg reported April 18.
Greg Glasgow
